Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,929 | -24,528 | -72,398 | -45,204 | -27,513 |
| Depreciation Amortization | 170 | 97 | 605 | 452 | 274 |
| Accounts payable and accrued liabilities | 1,114 | 192 | 792 | 752 | 408 |
| Other Working Capital | -4,879 | -6,219 | 12,515 | 2,619 | 3,228 |
| Other Operating Activity | 8,296 | 3,782 | 7,168 | 4,642 | 2,221 |
| Operating Cash Flow | $-50,228 | $-26,676 | $-51,318 | $-36,739 | $-21,382 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -96,150 | -84,589 | -26,252 | -19,231 | -33,252 |
| PPE Investments | -164 | -101 | -237 | -225 | -231 |
| Investing Cash Flow | $-96,314 | $-84,690 | $-26,489 | $-19,456 | $-33,483 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 376,749 | 129,486 | 40,006 | 39,947 | 39,594 |
| Financing Cash Flow | $376,749 | $129,486 | $40,006 | $39,947 | $39,594 |
| Beginning Cash Position | 30,376 | 30,692 | 68,177 | 68,177 | 68,177 |
| End Cash Position | 260,583 | 48,812 | 30,376 | 51,929 | 52,906 |
| Net Cash Flow | $230,207 | $18,120 | $-37,801 | $-16,248 | $-15,271 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,228 | -26,676 | -51,318 | -36,739 | -21,382 |
| Capital Expenditure | -164 | -101 | -237 | -225 | -231 |
| Free Cash Flow | -50,392 | -26,777 | -51,555 | -36,964 | -21,613 |